Arshad, Usman
Taubert, Max
Seeger-Nukpezah, Tamina
Ullah, Sami
Spindeldreier, Kirsten C.
Jaehde, Ulrich
Hallek, Michael
Fuhr, Uwe
Vehreschild, Jörg Janne
Jakob, Carolin
Funding for this research was provided by:
Universitätsklinikum Köln
Article History
Received: 8 February 2021
Accepted: 2 June 2021
First Online: 20 June 2021
Declarations
:
: In the study, data from the Cologne Cohort of Neutropenic Patients (CoCoNut) were used. CoCoNut was approved by the local ethics committee (name and email address: Ethics Committee of the Faculty of Medicine, University of Cologne, Cologne, Germany, ExternalRef removed; date of approval: 14.01.2014, approval file number: 13–108). CoCoNut is registered as data integration center at ClinicalTrials.gov (ClinicalTrials.gov identifier: NCT01821456). All methods were performed in accordance with the local and international guidelines and regulations. No interventions were performed as part of this study. Data collection and storage were carried out on site using current techniques of privacy assurance. In this scenario, according to legal regulations patient informed and verbal consent is waived in the state of North Rhine-Westphalia, Germany, which is confirmed by the decision of the Ethics Committee of the Faculty of Medicine, University of Cologne, Cologne, Germany.
: Not applicable.
: There are no financial and non-financial competing interests related to this study.